- Home
- BGNE vs ADM Comparison
BGNE vs ADM Comparison
Compare BGNE & ADM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGNE
- ADM
- Stock Information
- Founded
- BGNE 2010
- ADM 1902
- Country
- BGNE Cayman Islands
- ADM United States
- Employees
- BGNE N/A
- ADM N/A
- Industry
- BGNE Biotechnology: Pharmaceutical Preparations
- ADM Packaged Foods
- Sector
- BGNE Health Care
- ADM Consumer Staples
- Exchange
- BGNE Nasdaq
- ADM Nasdaq
- Market Cap
- BGNE 21.0B
- ADM 24.8B
- IPO Year
- BGNE 2016
- ADM N/A
- Fundamental
- Price
- BGNE $189.23
- ADM $53.35
- Analyst Decision
- BGNE Buy
- ADM Hold
- Analyst Count
- BGNE 7
- ADM 12
- Target Price
- BGNE $247.07
- ADM $62.92
- AVG Volume (30 Days)
- BGNE 281.8K
- ADM 3.2M
- Earning Date
- BGNE 11-12-2024
- ADM 11-25-2024
- Dividend Yield
- BGNE N/A
- ADM 3.75%
- EPS Growth
- BGNE N/A
- ADM N/A
- EPS
- BGNE N/A
- ADM 5.01
- Revenue
- BGNE $3,351,304,621.00
- ADM $88,768,000,000.00
- Revenue This Year
- BGNE $969.39
- ADM N/A
- Revenue Next Year
- BGNE $24.79
- ADM $1.92
- P/E Ratio
- BGNE N/A
- ADM $10.65
- Revenue Growth
- BGNE 50.22
- ADM N/A
- 52 Week Low
- BGNE $126.97
- ADM $48.92
- 52 Week High
- BGNE $248.16
- ADM $77.35
- Technical
- Relative Strength Index (RSI)
- BGNE 31.72
- ADM 42.32
- Support Level
- BGNE $189.60
- ADM $50.97
- Resistance Level
- BGNE $209.29
- ADM $52.94
- Average True Range (ATR)
- BGNE 6.42
- ADM 1.30
- MACD
- BGNE -2.10
- ADM -0.03
- Stochastic Oscillator
- BGNE 9.19
- ADM 50.11
About BGNE BeiGene Ltd.
BeiGene Ltd is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. BeiGene's key cancer treatments are BRUKINSA (zanubrutinib), Bruton's tyrosine kinase (BTK) inhibitor, and TEVIMBRA (tislelizumab), an anti-PD-1 antibody. In addition, it has a diverse pipeline of novel therapeutics focusing on a range of malignancies, including AML, MDS, multiple myeloma, lung, gastrointestinal, breast, and gynecologic cancers. The Company operates in one segment: pharmaceutical products and is primarily located in the U.S. and the PRC. Key revenue is generated from the U.S.
About ADM Archer-Daniels-Midland Company
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.